this time from chemchina according to reports that say the rejection stemmed from regulatory concerns. however the report adds that the two companies have not broken off talks and an agreement could still be reached in the next couple of weeks. >> now syngenta has been a big target for a number of years now. the company was first approached by u.s. rival monsanto in 2011. the offer was rejected. another offer came a year later, 2012 but that too was turned down. monsanto came back to the table this year. third time lucky maybe. it wasn't with a series of sweetened offers but walked away dropping it's bid for syngenta. that was worth $47 billion. the ceo then quit soon after the break down of the deal talks and the company has now rebuffed this chemchina offer as well. it's really interesting. we talked to the analyst a couple of minutes ago and he said syngenta doesn't have to merge with anyone. they're fine on their own. he made the point they have a 21% global market share. they are the market leader maybe they'll have to merge but not syngenta. the fact of the matter is that farm i

they are said to have rebuffed a $42 billion from chemchina. the rejections stem from regulatory concerns however the report adds the two companies have not broken off talks and an agreement could still be reached in the next few weeks. take a look at shares in syngenta this morning. now some of those gains but still up by 7.4%. now syngenta has been a big target for a number of years now. the company was first approached by monsanto in 2011. the offer was rejected. another offer came in 2012 but that too was rejected. they then came back to the table this year with a series of sweetened offered but ultimately walk addway dropping the bid for syngenta. that was worth $47 billion. now syngenta ceo quit soon after the breakdown of those talks and the company has now reportedly rejected this chemchina offer a well but you have to wonder whether this time its about regulatory concerns as the bloomberg report cited or whether it's still about price. i have a feeling that maybe syngenta will actually accept a price that is closer to monsanto's bid. t

the wildcard is chemchina.ignificance of effect that if this deal goes ahead -- this is what gets me -- it would be the largest ever deal or acquisition by a chinese company. what is the meaning of that? aaron: let's remember that thishina is state owned or is more than just an m&a deal. this is a clinical deal. they want to secure food supply, production. syngenta provides the broadest for the growth. that shows ambition beyond just commodities. they are going to manufacturing, technology, and that is what makes this interesting. mark: we have touched on some of the biggest this week. move to the u.s.. i lookedat my stats, at step go. the s&p 500 is set to end six consecutive weeks of gain? betty: their steepest loss in six weeks. it has been great for m&a but not great for the equity b ulls in the u.s.. abigail: shares of the nasdaq are trading lower, as well. for the fifth straight day in the rope, the nasdaq composite index is trading down off by 1% today. a big piece of it is retail. the shares are plungin

. >> syngenta rejected an initial bid from chemchina. it is based in beijing. talks continue with talks with other bidders. this comes after syngenta rejected a bid from monsanto a couple of times and comes after last week. dow jones reporting dupont is in potential talks with the agricultural player. we are looking at syngenta shares higher by % after hours. >> i think you were in the stock seven years ago? >> exactly. a long time ago when agriculture and commodities were hot. not so hot right now with the exception of something like orange juice. you're looking at yields in this space. i think you start to see these type of deals. i don't know if you can buy them monsanto off it. i think it's a one off for this company. >>> john malone has a bone to pick with bob iger. it has to do with the two most hated words in media, cord cutting. comments you've got to hear after the break. >> cisco shares falling on soft guidance. conference call under way. we'll hear from the ceo on what drove the quarter. >>> while everyone is worried about the sell-off in retail stoc